Biosynex SA (EPA:ALBIO)
0.8680
+0.0180 (2.12%)
Apr 21, 2026, 5:16 PM CET
Biosynex Market Cap
Biosynex has a market cap or net worth of €15.94 million as of April 21, 2026. Its market cap has decreased by -43.07% in one year.
Market Cap
15.94M
Enterprise Value
68.22M
Revenue
97.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.87
Market Cap Chart
Since March 25, 2011, Biosynex's market cap has increased from 8.12M to 15.94M, an increase of 96.20%. That is a compound annual growth rate of 4.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 15.94M | 42.62% |
| Dec 31, 2025 | 11.17M | -39.63% |
| Dec 31, 2024 | 18.51M | -78.44% |
| Dec 29, 2023 | 85.85M | -39.13% |
| Dec 30, 2022 | 141.04M | -51.35% |
| Dec 31, 2021 | 289.89M | 91.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Median Technologies | 188.81M |
| Carvolix | 178.32M |
| Guerbet | 124.26M |
| Diagnostic Medical Systems | 33.80M |
| Implanet | 29.91M |
| Theraclion | 28.86M |
| Novacyt | 27.10M |
| Ikonisys | 22.34M |